APOA5 Antikörper (N-Term)

Produktnummer ABIN543847

Produktdetails anti-APOA5 Antikörper

Target: APOA5 (Apolipoprotein A-V (APOA5))

Bindungsspezifität: N-Term

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser APOA5 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Verwendungszweck: Rabbit polyclonal antibody raised against synthetic peptide of APOA5.

Kreuzreaktivität: Human

Immunogen: A synthetic peptide (conjugated with KLH) corresponding to N-terminus of human APOA5.

Anwendungsinformationen

Applikationshinweise: Western Blot (1:1000)
Immunohistochemistry (1:10-50)
The optimal working dilution should be determined by the end user.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: In PBS (0.09 % sodium azide)

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Store at 4°C. For long term storage store at -20°C.
Aliquot to avoid repeated freezing and thawing.

Referenzen für anti-APOA5 Antikörper (ABIN543847)

Hubacek, Wang, Skodová, Adámková, Vráblík, Horínek, Stulc, Ceska, Talmud: "APOA5 Ala315>Val, identified in patients with severe hypertriglyceridemia, is a common mutation with no major effects on plasma lipid levels." in: Clinical chemistry and laboratory medicine : CCLM / FESCC, Vol. 46, Issue 6, pp. 773-7, (2008) (PubMed).

Dorfmeister, Zeng, Dichlberger, Nilsson, Schaap, Hubacek, Merkel, Cooper, Lookene, Putt, Whittall, Lee, Lins, Delsaux, Nierman, Kuivenhoven, Kastelein, Vrablik, Olivecrona, Schneider, Heeren et al.: "Effects of six APOA5 variants, identified in patients with severe hypertriglyceridemia, on in vitro lipoprotein lipase activity and receptor binding. ..." in: Arteriosclerosis, thrombosis, and vascular biology, Vol. 28, Issue 10, pp. 1866-71, (2008) (PubMed).

Luo, Kranzler, Zuo, Wang, Blumberg, Gelernter: "CHRM2 gene predisposes to alcohol dependence, drug dependence and affective disorders: results from an extended case-control structured association study." in: Human molecular genetics, Vol. 14, Issue 16, pp. 2421-34, (2005) (PubMed).

Details zu APOA5

Target: APOA5 (Apolipoprotein A-V (APOA5))

Andere Bezeichnung: Apolipoprotein A V (ApoA V) (APOA5 Produkte)

Synonyme: APOAV antikoerper, RAP3 antikoerper, 1300007O05Rik antikoerper, Apoav antikoerper, apo-AV antikoerper, apoA-V antikoerper, APOA5 antikoerper, MGC140487 antikoerper, rap3 antikoerper, apoav antikoerper, apoa-v antikoerper, apolipoprotein A5 antikoerper, apolipoprotein A-V antikoerper, apolipoprotein A5 L homeolog antikoerper, APOA5 antikoerper, Apoa5 antikoerper, apoa5.L antikoerper, apoa5 antikoerper

Gen-ID: 116519

Pathways: Regulation of Lipid Metabolism by PPARalpha, Lipid Metabolism